Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-07-22 | Artiva Biotherapeutics, Inc. | Shah Rajeev M.
(Director) |
P | Common Stock | A | 8333333 | $12.00 - $12.00 | $99,999,996 |
| 2024-07-22 | Artiva Biotherapeutics, Inc. | Shah Rajeev M.
(Director) |
J | Common Stock | A | 461687 | $10.20 - $10.20 | $4,709,207 |
| 2024-07-22 | Artiva Biotherapeutics, Inc. | Wellington Biomed...
(AtLeastTenPercentOwner) |
J | Common Stock | A | 49019 | $10.20 - $10.20 | $499,993 |
| 2024-07-22 | Artiva Biotherapeutics, Inc. | GOODMAN COREY S
(AtLeastTenPercentOwner) |
P | Common Stock | A | 416666 | $12.00 - $12.00 | $4,999,992 |
| 2024-07-22 | Artiva Biotherapeutics, Inc. | GC Cell Corp
(AtLeastTenPercentOwner) |
P | Common Stock | A | 2083332 | $12.00 - $12.00 | $24,999,984 |
| 2024-07-22 | Artiva Biotherapeutics, Inc. | GC Cell Corp
(AtLeastTenPercentOwner) |
J | Common Stock | A | 550433 | $10.20 - $10.20 | $5,614,416 |
| 2024-07-22 | Artiva Biotherapeutics, Inc. | Huh Yong-Jun
(Director) |
P | Common Stock | A | 2083332 | $12.00 - $12.00 | $24,999,984 |
| 2024-07-22 | Artiva Biotherapeutics, Inc. | Huh Yong-Jun
(Director) |
J | Common Stock | A | 550433 | $10.20 - $10.20 | $5,614,416 |
| 2024-07-22 | Artiva Biotherapeutics, Inc. | Aslan Fred
(President and CEO) |
A | Common Stock | A | 228905 | $0.00 - $0.00 | $0 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |